Clinical Trial Update: Effect of Roflumilast on Airway Blood Flow as an Expression of Airway Inflammation in COPD [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/Phase 2 trials investigated whether roflumilast reduces airway inflammation in chronic obstructive pulmonary disease by altering airway blood flow. Resu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Roflumilast (roflumilast)

Snippet

Sponsor: University of Miami | Conditions: COPD | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2017-08-18